NSC292156
| dc.creator | US National Cancer Institute | en_GB |
| dc.date.accessioned | 2006-05-02T15:37:10Z | |
| dc.date.available | 2006-05-02T15:37:10Z | |
| dc.date.created | 2003-02-01 | en_GB |
| dc.date.issued | 2006-05-02T15:37:10Z | |
| dc.format.extent | 8762 bytes | |
| dc.format.extent | 7739 bytes | |
| dc.format.mimetype | chemical/x-cml | |
| dc.format.mimetype | chemical/x-cml | |
| dc.identifier | NSC292156 | en_GB |
| dc.identifier.ichi | C23H27N3O2,1H3-17-20(21(27)26(24(17)3H3)19-12H-8H-5H-9H-13H-19)16H2-25-14H2-15H2-28-23H(22H(25)2H3)18-10H-6H-4H-7H-11H-18 | en_GB |
| dc.identifier.inchi | InChI=1S/C23H27N3O2/c1-17-21(23(27)26(24(17)3)20-12-8-5-9-13-20)16-25-14-15-28-22(18(25)2)19-10-6-4-7-11-19/h4-13,18,22H,14-16H2,1-3H3/t18-,22-/m0/s1 | |
| dc.identifier.inchikey | OOGNFQMTGRZRAB-AVRDEDQJSA-N | |
| dc.identifier.uri | http://www.dspace.cam.ac.uk/handle/1810/160733 | |
| dc.language.iso | en_GB | |
| dc.publisher | Unilever Center for Molecular Informatics, Cambridge University | en_GB |
| dc.title | NSC292156 | en_GB |
| dc.title.alternative | Antipyrine, 4-[(3-methyl-2-phenylmorpholino)methyl]- (8CI) | en_GB |
| dc.title.alternative | Morazone | en_GB |
| dc.title.alternative | Novartrina | en_GB |
| dc.title.alternative | Orsimon | en_GB |
| dc.title.alternative | R 445 | en_GB |
| dc.title.alternative | Tarugan | en_GB |
| dc.title.alternative | WLN: T6N DOTJ B1 CR& A1- DT5NNVJ A1 BR E1 | en_GB |
| dc.title.alternative | 3-Pyrazolin-5-one, 2, 3-dimethyl-4-(3-methyl-2-phenylmorpholino)methyl-1-phenyl- | en_GB |
| dc.title.alternative | 3H-Pyrazol-3-one, 1,2-dihydro-1, 5-dimethyl-4-[(3-methyl-2-phenyl-4-morpholinyl)methyl]-2-phenyl- (9CI) | en_GB |
| dc.title.alternative | 4-(2'-Phenyl-3'-methylmorpholinomethyl)-1-phenyl-2, 3-dimethyl-3-pyrazoline-5-one | en_GB |
| dc.title.alternative | 4-[(3-Methyl-2-phenylmorpholino)methyl]antipyrine | en_GB |
| dc.type | Chemical Structures | en_GB |